Roche pulls plug on Inovio deal
Roche has pulled the plug on its collaboration with Inovio after stepping away from the development of the second candidate, the hepatitis B DNA immunotherapy INO-1800.
Read More
Tag: Inovio
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
